Author Archives | SandraKitchen
SandraKitchen - who has written 21 posts on FavStocks.
Sandra has been avidly involved in watching the stock market and writing about the stock movements that interest investors. She specializes in small and mid-cap Biotech stocks with a main focus on public companies awaiting FDA approval of new drugs and/or products.
living in New York, with her family and pets, she stays up on the latest news from the New York Stock Exchange and the FDA. Her goal is to bring the news to investors from a fresh, unbiased, pure research point of view.
FDA Update and Applications Awaiting Approval (CTIC NSPH, AUXL)
Cell Therapeutics, Inc. (Public, NASDAQ:CTIC) recently released their second quarter figures for 2009 and stated it was a transforming quarter for the company, in which they eliminated 44.5% of their outstanding debt. They also released data on their latest drug at the American Society of Clinical Oncology Annual Meeting and have also completed their submission [...]
Continue reading...
27 August 2009
View Comments